Soo-jin T. Oh
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
From infection to dysfunction: viral triggers and antiviral immune factors in Alzheimer's disease pathology.
Journal: Frontiers in immunology
Published: March 26, 2026
In-depth multimodal validation of 18F-THK5351 for imaging monoamine oxidase-B-mediated reactive astrogliosis in Alzheimer's and related neurodegenerative diseases.
Journal: Experimental & molecular medicine
Published: January 06, 2026
Effect of inspired oxygen fraction during anesthesia on inflammation and antioxidant enzyme activity in the mouse cortex and hippocampus.
Journal: Frontiers in aging neuroscience
Published: December 05, 2025
Vitisin B, extracted from Vitis vinifera, enhances memory function and neuroprotective effects in scopolamine-induced memory-impaired mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 01, 2025
Microglial MARCO facilitates Varicella zoster virus uptake and triggers TLR2-mediated neuroinflammation.
Journal: Journal of biomedical science
Published: October 09, 2025
Neuroprotective effects of Gnetin H from Paeonia lactiflora via CREB-BDNF pathway restoration in a scopolamine-induced memory deficit model.
Journal: European journal of pharmacology
Published: April 18, 2025
Elevated O-GlcNAcylation Enhances Metabolic Rate and Reduces the Excitability of Hypothalamic ARC Neurons in 10-month-old Male Mice.
Journal: Experimental neurobiology
Published: April 07, 2025
Enhanced Cognitive and Memory Functions via Gold Nanoparticle-Mediated Delivery of Afzelin through Synaptic Modulation Pathways in Alzheimer's Disease Mouse Models.
Journal: ACS chemical neuroscience
Published: February 20, 2025
3',4',7-trihydroxyflavone activates the CREB-BDNF axis and restores scopolamine-induced memory deficit in mice.
Journal: European journal of pharmacology
Published: January 31, 2025
Hemoglobin as a pseudoperoxidase and drug target for oxidative stress-related diseases.
Journal: Signal transduction and targeted therapy
Published: January 21, 2025
Novel mouse model of Alzheimer's disease exhibits pathology through synergistic interactions among amyloid-β, tau, and reactive astrogliosis.
Journal: Zoological research
Published: January 05, 2025
Pharmacological targeting of mitophagy via ALT001 improves herpes simplex virus 1 (HSV1)-mediated microglial inflammation and promotes amyloid β phagocytosis by restricting HSV1 infection.
Journal: Theranostics
Published: October 28, 2024
Last Updated: 09/26/2026